the medium with fresh medium containing 0.1% bovine serum albumin (BSA), TPA and activins were added to each well. Following 24 h of culture, the amount of HGF secreted into the conditioned medium and present in the cell extract was determined by enzyme-linked immunoadsorbent assay with a Human HGF AN'ALYZA Immunoassay Kit (Genzyme TECHNE Mineapolis, U.S.A), and the cells were counted with a hemocytometer. The cell extract was prepared by the method of Matsunaga et al. 19) Total RNA Isolation and Reverse Transcription-PCR Total cellular RNA was extracted from the cells with a QuickPrep TM Total RNA EXTRACTION Kit (Amersham Pharmacia Biotech, Bucks U.K.). Total RNA (3 mg) from MRC-5 cells was reverse-transcribed with Ready-To-Go TM You-Prime First-Strand Beads (Amersham Pharmacia Biotech) and random hexanucleotide primer. Subsequent amplification was carried out for 30 cycles under the following conditions: 95°C for 30 s, 55°C for 30 s, and 72°C for 1 min. The oligonucleotide sequences used for RT-PCR were obtained from published cDNA sequences and are listed in the 5Ј to 3Ј direction with coordinates as reported: human HGF sense primer (nt 979-1000 of human HGF cDNA) 5Ј-CAGCGT-TGGGATTCTCAGTAT-3Ј and antisense primer (nt 1497-1518) 5Ј-CCTATGTTTGTTCGTGTTGGA-3Ј 23) /human glyceraldehydephosphate dehydogenase (GAPDH) sense primer (nt 39-57 of human GAPDH cDNA) 5Ј-GAAGGTGAAG-GTCGGAGTC-3Ј and antisense primer (nt 244-264) 5Ј-GAAGATGGTGATGGGATTTC-3Ј. 24) Cloning of PCR Products The PCR products were cloned in pT7Blue vector (Novagen, Madison WI) with Ligation High (Toyobo, Japan) and transformed in E. coli strain DH5a and Competent High (Toyobo, Japan).
Northern Blot Analysis A 20 mg sample of total RNA per lane was electrophoresed on a 1% agarose/6.7% formalde- The effect of activins A, AB, and B on hepatocyte growth factor (HGF) synthesis stimulated by 12-Otetradecanoylphorbol b b-acetate (TPA) was studied in MRC-5 human lung fibroblasts. Activins A, AB, and B inhibited the increase in HGF secretion induced by TPA in different dose-dependent manners and potencies. At 5 ng/ml, activins A and AB inhibited the increase approximately 30% and 10%, respectively, and at 25 ng/ml both activins produced almost maximal inhibition, i.e., approximately 40%. Activin B caused 10% inhibition at 12 ng/ml, and at 25 ng/ml produced almost maximal inhibition, approximately 30%. Further analysis with activin A indicated that the inhibition was caused by decreased HGF mRNA levels, followed by decreased cellular HGF levels. At 25 ng/ml, activin A inhibited the increase in HGF in the cellular lysate and the increase in HGF mRNA level approximately 80% and 40%, respectively.
hyde gel, and the gel was transferred to Hybond-Nϩ (Amersham Pharmacia Biotech) and baked for 2 h. The blot was prehybridized at 70°C for 1 h in Rapid-hyb buffer (Amersham Pharmacia Biotech) and then hybridized with [a-32 P]dCTP-labeled human HGF cDNA fragment at 70°C for 3 h. After washing with 1XSSC and 0.1% sodium dodecyl sulfate (SDS) at 65°C for 15 min, the blot was subjected to autoradiography, analyzed with a Fuji BAS 2000, and photographed with a Fuji Pictrography 3000 (Fuji Photo Film, Tokyo, Japan). The blot was stripped and reprobed with [a-32 P]dCTP-labeled human GAPDH cDNA fragment, washed, and subjected to autoradiography as described above. The human HGF and GAPDH probes were labeled with [a-32 P]dCTP by using the Redprime II DNA labeling system (Amersham Pharmacia Biotech). Densitometric analysis was carried out using NIH Image software.
RESULTS

Effect of Activins A, AB, and B on the Increase in HGF Secretion
Induced by TPA The effect of activins A, AB, and B on the increase in HGF secretion induced by TPA was studied in MRC-5 human lung fibroblasts. rh activin A and porcine activins A, AB, and B inhibited the increase in HGF secretion in a dose-dependent manner (Fig. 1) , although the dose dependencies and maximum inhibitions differed. At 5 ng/ml, rh and porcine activin A and porcine activin AB inhibited the increase approximately 30 and 10%, respectively, and the 25 ng/ml concentration of these activins produced almost maximal inhibition, approximately 40%. By contrast, porcine activin B caused only 10% inhibition even at 12 ng/ml, and the 25 ng/ml concentration produced almost maximal inhibition, approximately 30%. None of these activins had any effect on HGF secretion in the controls (data not shown).
Effect of Activin A on the Increase in Cellular HGF Induced by TPA Next we used rh activin A to examine whether the inhibition of HGF secretion was attributable to a decrease in cellular HGF or HGF secretion. rh activin A (25 ng/ml) inhibited the increase in cellular HGF induced by TPA by about 80% (Table 1) .
Effect of Activin A on the Increase in HGF mRNA Level Induced by TPA We then examined the effect of rh activin A on the increase in HGF mRNA level induced by TPA. Northern blot analysis showed that rh activin A (25 ng/ml) inhibited the increase in HGF mRNA level by TPA (Fig. 2) , and the densitometric measurement indicated that the inhibition was about 40%.
DISCUSSION
The results of this study show that activins A, AB, and B inhibit the increase in HGF secretion induced by TPA in MRC-5 human lung fibroblasts, and analysis with rh activin A demonstrated that the inhibition was due to a decrease in HGF mRNA level, followed by a decrease in HGF synthesis.
Activin was originally identified as a stimulator of folliclestimulating hormone secretion. [25] [26] [27] Later, activins were shown to be expressed in various organs during development and in acquired conditions, and to have a wide variety of biological functions, including regulation of cell proliferation and differentiation, and induction of mesodermal tissues during amphibian development. (b B , b B ) , respectively. 32) Interestingly, the inhibitory actions of these activins differ from each other (Fig. 1) . Their potencies correlated with the number of b A subunits they contained, indicating that b A is a more potent inhibitor than b B .
The secretion of HGF was not inhibited by more than about 50% when the concentrations of activins A and B concentrations were measured to above 12.5 mg/ml. A similar degree of inhibition has been obtained in TPA-stimulated HGF secretion in MRC-5 cells by the maximum effective concentrations of TGF-b1 or dexamethasone. 22) This partial inhibition by these factors may be due to the fact that the stimulation of HGF gene transcription by TPA partially precedes the appearance of inhibitory actions by these factors. The degree of decrease of cellular HGF by rh activin A seems to be higher than its degree of decrease of HGF secretion. Since the HGF synthesized in the cells is secreted in the culture medium, the cellular extract values reflect the rate of synthesis of HGF at the time of the cellular extract was prepared. Therefore, its higher decrease of cellular HGF may be attributable to the decrease in the stimulatory response of TPA at the time.
In evaluating the significance of the present results, it seems important to know whether the change in activin levels affects the HGF level and then the HGF action in vivo, and several lines of evidence suggest that inhibition of HGF synthesis by activins is biologically meaningful, as described below.
In partially hepatectomized rat liver, b A mRNA was increased at 24 h and remained elevated for at least 72 h.
33) The expression of HGF mRNA increases in rat liver and lung 3 to 6 h after partial hepatectomy and remains elevated for 24 h and 12 h, respectively. 34) We and other groups showed that activin A and AB inhibited DNA synthesis in primary cultured rat hepatocytes stimulated with HGF or epidermal growth factor, 33, 35) although the effective concentration of activin AB was higher than that of activin A. 35) Therefore, the later increase in activin A and AB may play an important role in terminating hepatocyte growth by inhibiting both HGF synthesis and HGF-stimulated DNA synthesis.
Increased levels of activin A have been found in experimentally induced fibrosis liver in rats 36) and in the serum of cirrhotic patients with hepatocellular carcinoma. 37) The HGF mRNA level decreased after the initial increase in a rat model of cirrhosis 38) and did not change in the liver after partial hepatectomy in rats with cirrhosis. 39) In humans, no HGF expression was detected in hepatocellular carcinoma tissue 40) or in the liver in fulminant hepatic failure. 41) Since HGF administration has been shown to prevent liver cirhhosis and fulminant hepatic failure, [42] [43] [44] these pathological states of the liver may be partially attributable to inhibition of HGF synthesis by activins.
Activin A activity was found to be reduced in chronic renal failure patients due to the binding to its inhibitor, 45) and the serum HGF levels of chronic renal failure patients are increased. 46, 47) Since HGF administration has preventive and therapeutic effects in chronic renal failure, 48 ) the reduction of active activin A in chronically injured renal tissue may result in the increase of HGF level and promotion of the compensatory growth of tubular components.
We also recently found that the b B mRNA level was increased at 1 h in the carbon-tetrachloride-induced rat liver regeneration model, peaked at 3 h, and remained constant up to 24 h. 49) As the effect of activin B is relatively weak compared with other activins (Fig. 1) , the early increase in activin B may play a role in moderating the excess growth stimulatory response of HGF by inhibiting HGF synthesis during the growth period.
In conclusion, we have shown that activins inhibit the increase in HGF synthesis induced by TPA in MRC-5 human lung fibroblasts and suggest that the inhibitory action of activins may play an important role in regulation of the biological functions of HGF in physiological and pathological conditions in vivo.
